SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-11-12 11:45
Tx date 2025-11-12 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,100
+5,500 vol
$0.20 each 		2,022,549
Filed 2025-11-10 15:31
Tx date 2025-10-31 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,498
+11,899 vol
$0.21 each 		11,899
Filed 2025-11-10 15:24
Tx date 2021-06-14 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Johnson, Neil Allan
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-05 16:30
Tx date 2025-10-31 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Pedram, Babak
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+11,899 vol 		75,449
Filed 2025-11-04 08:08
Tx date 2025-10-31 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
46 - Compensation for services 		$2,498
+11,899 vol
$0.21 each 		91,336
Filed 2025-10-14 16:47
Tx date 2025-10-14 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,515
+49,000 vol
$0.235 each 		2,017,049
Filed 2025-08-28 13:10
Tx date 2025-08-28 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,800
+20,000 vol
$0.24 each 		1,968,049
Filed 2025-08-28 13:09
Tx date 2025-08-28 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,350
+10,000 vol
$0.235 each 		1,948,049
Filed 2025-08-15 11:09
Tx date 2025-08-15 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Renaissance Mercantile Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$6,965
+35,000 vol
$0.199 each 		5,259,000
Filed 2025-08-13 11:05
Tx date 2025-08-13 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,900
+10,000 vol
$0.19 each 		1,938,049
Filed 2025-08-12 16:59
Tx date 2025-08-12 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,600
+40,000 vol
$0.19 each 		1,928,049
Filed 2025-08-12 16:59
Tx date 2025-08-12 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,760
+20,000 vol
$0.188 each 		1,888,049
Filed 2025-08-08 14:22
Tx date 2025-08-08 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,500
+25,000 vol
$0.18 each 		1,868,049
Filed 2025-08-08 14:21
Tx date 2025-08-08 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,625
+25,000 vol
$0.185 each 		1,843,049
Filed 2025-08-06 15:37
Tx date 2025-08-06 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Matheson, Joseph Roderick
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,250
+25,000 vol
$0.17 each 		1,818,049
Filed 2025-08-06 15:18
Tx date 2025-07-31 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
97 - Other 		$12,709
+79,437 vol
$0.16 each 		79,437
Filed 2025-08-06 15:11
Tx date 2022-02-15 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-08-06 15:10
Tx date 2022-02-15 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-08-06 15:06
Tx date 2022-02-15 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Smallbone, Sidney Randall
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-08-06 14:34
Tx date 2025-07-31 		$MRVL
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. 		Pedram, Babak
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+63,550 vol 		63,550